Vascular Biogenics Ltd (VBLT)

[davidal66]

Thanks for you input. I appreciate it. I am still extremely bullish here. My critique about analysts is not confined to VBLT; it's industry wide. I was very well versed on SRPT, studied the data, but was always blown away by how much more the analysts seemed to know. This was especially true immediately prior to the earthquake FDA approval. I shared the bullish scenario, but clearly the analysts and their 'spokesperson' Adam Feurstein had the inside tract on approval. This is one of many examples. It's not that the analysts are that smart, it's that they have banking relationships(or desire such relationships) and that can spark loose lips IMHO. I'm always curious about the 'breakout sessions' after a company presents at a conference.